BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease (opens in new tab)

BioRestorative Therapies, Inc. announced expanded blinded data from its fully enrolled Phase 2 clinical trial evaluating BRTX-100. The post BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease appeared first on Orthopedics This Week.